DE68902753D1 - Mittel zur erhoehung des transdermalen penetrationsflusses. - Google Patents

Mittel zur erhoehung des transdermalen penetrationsflusses.

Info

Publication number
DE68902753D1
DE68902753D1 DE8989301896T DE68902753T DE68902753D1 DE 68902753 D1 DE68902753 D1 DE 68902753D1 DE 8989301896 T DE8989301896 T DE 8989301896T DE 68902753 T DE68902753 T DE 68902753T DE 68902753 D1 DE68902753 D1 DE 68902753D1
Authority
DE
Germany
Prior art keywords
human
increasing
transdermal administration
lower animal
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989301896T
Other languages
English (en)
Other versions
DE68902753T2 (de
Inventor
Russell Owen Potts
Michael Lee Francoeur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE68902753D1 publication Critical patent/DE68902753D1/de
Publication of DE68902753T2 publication Critical patent/DE68902753T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8989301896T 1988-02-29 1989-02-24 Mittel zur erhoehung des transdermalen penetrationsflusses. Expired - Fee Related DE68902753T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16192688A 1988-02-29 1988-02-29

Publications (2)

Publication Number Publication Date
DE68902753D1 true DE68902753D1 (de) 1992-10-15
DE68902753T2 DE68902753T2 (de) 1993-01-21

Family

ID=22583397

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989301896T Expired - Fee Related DE68902753T2 (de) 1988-02-29 1989-02-24 Mittel zur erhoehung des transdermalen penetrationsflusses.

Country Status (11)

Country Link
EP (1) EP0331382B1 (de)
JP (1) JPH0768147B2 (de)
AT (1) ATE80313T1 (de)
CA (1) CA1331137C (de)
DE (1) DE68902753T2 (de)
DK (1) DK93289A (de)
ES (1) ES2051998T3 (de)
FI (1) FI92650C (de)
GR (1) GR3005657T3 (de)
IE (1) IE61946B1 (de)
PT (1) PT89837B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0425443A1 (de) * 1989-10-27 1991-05-02 Ciba-Geigy Ag Injizierbares parasitizides Mittel
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
DE59003020D1 (de) * 1990-04-26 1993-11-11 Sagitta Arzneimittel Gmbh Piroxicam enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
WO1992017185A1 (en) * 1991-03-29 1992-10-15 University Of Florida Targeted drug delivery via mixed phosphate derivatives
EP0612526A4 (de) * 1991-11-15 1995-08-02 Ss Pharmaceutical Co Entzündungshemmendes und analgetisches pflaster.
ES2160623T3 (es) * 1992-12-31 2001-11-16 Sunkyong Ind Ltd Composiciones farmaceuticas mejoradas para la penetracion en la piel de piroxicam.
DE4341572C1 (de) * 1993-12-07 1995-06-22 Univ Dresden Tech Zahnriemengetriebe
GB9404248D0 (en) * 1994-03-05 1994-04-20 Boots Co Plc Pharmaceutical formulations
US6106856A (en) * 1994-03-09 2000-08-22 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Transdermal delivery of calcium channel blockers, such as nifedipine
UA48212C2 (uk) 1996-01-31 2002-08-15 Сергей Дмітрієвіч БУРЛАКОВ Антиглюкокортикоїдний лікарський засіб
CN1252003A (zh) * 1997-03-31 2000-05-03 强生消费者公司 增强药物化合物渗透作用的溶剂系统
PT1510213E (pt) 1997-11-10 2009-02-12 Strakan Internat Ltd Uma Socie Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona
JP4626202B2 (ja) * 2003-07-16 2011-02-02 大正製薬株式会社 ピロキシカム含有外用消炎鎮痛剤組成物
JP2006188500A (ja) * 2004-12-08 2006-07-20 Toyama Chem Co Ltd ピロキシカムを含有する外用液剤
CA2728727C (en) * 2008-06-24 2018-01-23 Intervet International B.V. Pharmaceutical transdermal compositions and method for treating inflammation in cattle
GB0906868D0 (en) * 2009-04-21 2009-06-03 Rabin Bennie Amlodipine salt compositions
IL279121B2 (en) 2018-06-01 2024-06-01 Tavanta Therapeutics Hungary Incorporated Topical amlodipine salts for the treatment of ringworm diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS59216818A (ja) * 1983-05-26 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
JPS60199834A (ja) * 1984-03-23 1985-10-09 Takeda Chem Ind Ltd 経皮吸収外用製剤
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions

Also Published As

Publication number Publication date
DE68902753T2 (de) 1993-01-21
CA1331137C (en) 1994-08-02
PT89837A (pt) 1989-10-04
JPH023613A (ja) 1990-01-09
IE890642L (en) 1989-08-29
EP0331382A3 (en) 1990-05-30
PT89837B (pt) 1994-01-31
IE61946B1 (en) 1994-11-30
EP0331382A2 (de) 1989-09-06
DK93289A (da) 1989-08-30
FI890930A (fi) 1989-08-30
FI92650C (fi) 1994-12-27
FI92650B (fi) 1994-09-15
GR3005657T3 (de) 1993-06-07
DK93289D0 (da) 1989-02-27
ES2051998T3 (es) 1994-07-01
EP0331382B1 (de) 1992-09-09
FI890930A0 (fi) 1989-02-27
ATE80313T1 (de) 1992-09-15
JPH0768147B2 (ja) 1995-07-26

Similar Documents

Publication Publication Date Title
ATE64306T1 (de) Mittel zur erhoehung der transdermalen permeation.
DE68902753D1 (de) Mittel zur erhoehung des transdermalen penetrationsflusses.
ATE7689T1 (de) 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
ATE310738T1 (de) Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
FR2410641A1 (fr) Formes racemiques et optiquement actives de (biphenylyl-4)-2 n-(diethylamino alkyl) propionamides et de leurs sels utiles comme agents spasmolytiques et procedes de preparation
ATE214269T1 (de) Oral anzuwendende flüssige arzneilösung
KR830009776A (ko) 세포 보호 유도방법
RU99118510A (ru) Композиция для лечения или предупреждения рака простаты
ES421570A1 (es) Un procedimiento para la preparacion de nuevos derivados de cianopregnenona.
JPS568315A (en) Antitumor agent
ATE41774T1 (de) (+)-cyanidan-3-ol derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung.
RU2053228C1 (ru) Производные пептидов, способ их получения, фармацевтическая композиция, ингибирующая эластазу человеческих лейкоцитов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee